EC
EntryPoint Capital Portfolio holdings
AUM
$200M
1-Year Return
6.93%
This Quarter Return
+2.29%
1 Year Return
+6.93%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$112M
AUM Growth
+$7.22M
(+6.9%)
Cap. Flow
+$4.02M
Cap. Flow
% of AUM
3.6%
Top 10 Holdings %
Top 10 Hldgs %
3.56%
Holding
1,843
New
513
Increased
412
Reduced
455
Closed
458
Top Buys
| 1 |
Unisys
UIS
|
$454K |
| 2 |
Sutro Biopharma
STRO
|
$394K |
| 3 |
Agilysys
AGYS
|
$382K |
| 4 |
Schrodinger
SDGR
|
$371K |
| 5 |
REV Group
REVG
|
$345K |
Top Sells
| 1 |
NextDecade
NEXT
|
$643K |
| 2 |
American Well
AMWL
|
$535K |
| 3 |
B. Riley Financial
RILY
|
$524K |
| 4 |
Lexicon Pharmaceuticals
LXRX
|
$496K |
| 5 |
Taysha Gene Therapies
TSHA
|
$484K |
Sector Composition
| 1 | Healthcare | 20.49% |
| 2 | Industrials | 17.08% |
| 3 | Technology | 16.88% |
| 4 | Financials | 12.63% |
| 5 | Consumer Discretionary | 12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Goodyear
GT
$2.43B
| $118K | 0.11% |
8,609
+5,415
| +170% | +$74.3K |
|
327
Tesla
TSLA
$1.13T
| $118K | 0.11% |
670
+486
| +264% | +$85.4K |
|
328
Mercer International
MERC
$216M
| $118K | 0.11% |
+11,827
| New | +$118K |
|
329
BridgeBio Pharma
BBIO
$10.2B
| $117K | 0.1% |
+3,778
| New | +$117K |
|
330
Preformed Line Products
PLPC
$946M
| $117K | 0.1% |
907
-1,454
| -62% | -$187K |
|
331
Qualys
QLYS
$4.87B
| $116K | 0.1% |
+696
| New | +$116K |
|
332
Quest Diagnostics
DGX
$20.5B
| $116K | 0.1% |
872
+832
| +2,080% | +$111K |
|
333
Progress Software
PRGS
$1.88B
| $116K | 0.1% |
2,176
+1,977
| +993% | +$105K |
|
334
Madison Square Garden
MSGS
$4.71B
| $116K | 0.1% |
+628
| New | +$116K |
|
335
Black Hills Corp
BKH
$4.35B
| $116K | 0.1% |
2,117
+2,057
| +3,428% | +$112K |
|
336
Alphabet (Google) Class A
GOOGL
$2.84T
| $115K | 0.1% |
765
+163
| +27% | +$24.6K |
|
337
WEC Energy
WEC
$34.7B
| $115K | 0.1% |
+1,406
| New | +$115K |
|
338
Penumbra
PEN
$11B
| $115K | 0.1% |
517
+439
| +563% | +$98K |
|
339
Abbott
ABT
$231B
| $115K | 0.1% |
1,014
+647
| +176% | +$73.5K |
|
|
DADA
340
DELISTED
Dada Nexus
DADA
| $115K | 0.1% |
55,899
+22,936
| +70% | +$47K |
|
341
Olaplex Holdings
OLPX
$994M
| $114K | 0.1% |
59,452
-30,768
| -34% | -$59.1K |
|
342
Manitowoc
MTW
$359M
| $114K | 0.1% |
8,041
-4,419
| -35% | -$62.5K |
|
343
Park Hotels & Resorts
PK
$2.4B
| $113K | 0.1% |
6,488
+2,260
| +53% | +$39.5K |
|
344
Intellia Therapeutics
NTLA
$1.29B
| $113K | 0.1% |
4,122
+1,563
| +61% | +$43K |
|
345
TFS Financial
TFSL
$3.82B
| $113K | 0.1% |
+9,001
| New | +$113K |
|
346
Blue Owl Capital
OWL
$11.6B
| $113K | 0.1% |
5,992
-3,908
| -39% | -$73.7K |
|
347
iHeartMedia
IHRT
$315M
| $113K | 0.1% |
54,016
-211,762
| -80% | -$443K |
|
|
PLYM
348
Plymouth Industrial REIT
PLYM
$998M
| $112K | 0.1% |
4,997
+1,266
| +34% | +$28.5K |
|
|
WBA
349
DELISTED
Walgreens Boots Alliance
WBA
| $112K | 0.1% |
5,176
+4,903
| +1,796% | +$106K |
|
350
Monte Rosa Therapeutics
GLUE
$305M
| $112K | 0.1% |
+15,893
| New | +$112K |
|